3D Medicines Wins Hong Kong Arbitration; SELLAS Ordered to Pay HK$7.98 Million in Costs

Bulletin Express

Jul 27

3D Medicines Inc. (3D Medicines) has secured a favorable final award in its arbitration with U.S.-based SELLAS Life Sciences Group at the Hong Kong International Arbitration Center. All of SELLAS’s claims were dismissed, and the sole arbitrator ordered SELLAS to reimburse 3D Medicines for arbitration costs totaling HK$7.98 million. The amount must be settled within 14 days of the award date, or by 7 August 2026; any overdue balance will accrue interest at an annual rate of 8%.

The award does not affect the existing licence agreement between the two companies. 3D Medicines will continue to advance the development and commercialization of oncology asset 3D189 in Greater China under the original terms.

The company advised shareholders and potential investors to exercise prudence when trading its securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1176044023"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176044023\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176044023?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176044023","market":"us","top_or_hot":-1,"title":"3D Medicines Wins Hong Kong Arbitration; SELLAS Ordered to Pay HK$7.98 Million in Costs","media":"Bulletin Express","content":"<p>3D Medicines Inc. (3D Medicines) has secured a favorable final award in its arbitration with U.S.-based SELLAS Life Sciences Group at the Hong Kong International Arbitration Center. All of SELLAS’s claims were dismissed, and the sole arbitrator ordered SELLAS to reimburse 3D Medicines for arbitration costs totaling HK$7.98 million. The amount must be settled within 14 days of the award date, or by 7 August 2026; any overdue balance will accrue interest at an annual rate of 8%.</p>\n<p>The award does not affect the existing licence agreement between the two companies. 3D Medicines will continue to advance the development and commercialization of oncology asset 3D189 in Greater China under the original terms.</p>\n<p>The company advised shareholders and potential investors to exercise prudence when trading its securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3D Medicines Wins Hong Kong Arbitration; SELLAS Ordered to Pay HK$7.98 Million in Costs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3D Medicines Wins Hong Kong Arbitration; SELLAS Ordered to Pay HK$7.98 Million in Costs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-27 23:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>3D Medicines Inc. (3D Medicines) has secured a favorable final award in its arbitration with U.S.-based SELLAS Life Sciences Group at the Hong Kong International Arbitration Center. All of SELLAS’s claims were dismissed, and the sole arbitrator ordered SELLAS to reimburse 3D Medicines for arbitration costs totaling HK$7.98 million. The amount must be settled within 14 days of the award date, or by 7 August 2026; any overdue balance will accrue interest at an annual rate of 8%.</p>\n<p>The award does not affect the existing licence agreement between the two companies. 3D Medicines will continue to advance the development and commercialization of oncology asset 3D189 in Greater China under the original terms.</p>\n<p>The company advised shareholders and potential investors to exercise prudence when trading its securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01244","symbol_name":"思路迪医药股份","start_time":0,"source_url":"","article_id":"1176044023","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176044023","pubTimestamp":1785165841,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"3D Medicines Inc. (3D Medicines) has secured a favorable final award in its arbitration with U.S.-based SELLAS Life Sciences Group at the Hong Kong International Arbitration Center. All of SELLAS’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01244":"思路迪医药股份"},"translate_title":"3D Medicines赢得香港仲裁；SELLAS被勒令支付798万港元的费用","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01244":1},"content_text":"3D Medicines Inc. (3D Medicines) has secured a favorable final award in its arbitration with U.S.-based SELLAS Life Sciences Group at the Hong Kong International Arbitration Center. All of SELLAS’s claims were dismissed, and the sole arbitrator ordered SELLAS to reimburse 3D Medicines for arbitration costs totaling HK$7.98 million. The amount must be settled within 14 days of the award date, or by 7 August 2026; any overdue balance will accrue interest at an annual rate of 8%.\nThe award does not affect the existing licence agreement between the two companies. 3D Medicines will continue to advance the development and commercialization of oncology asset 3D189 in Greater China under the original terms.\nThe company advised shareholders and potential investors to exercise prudence when trading its securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}